Natural Product-Derived Modulators of Cell Cycle Progression and Viral Entry by Enantioselective Oxa Diels-Alder Reactions on the Solid Phase

Chemistry and Biology

Volumn 14, Issue 4, 2007, Pages 443-451

  Leßmann, Torben ^a,b,e   Leuenberger, Michele G ^a,b   Menninger, Sascha ^a,b,e   Lopez Canet, Meritxell ^a,b   Müller, Oliver ^a   Hümmer, Stefan ^c,e   Bormann, Jenny ^c,e   Korn, Kerstin ^d,e   Fava, Eugenio ^d,e   Zerial, Marino ^d,e   Mayer, Thomas U ^c,e   Waldmann, Herbert ^a,b,e  

^a MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^b TU DORTMUND UNIVERSITY   (Germany)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^e CHEMICAL GENOMICS CENTRE OF THE MAX PLANCK SOCIETY   (Germany)

Author keywords

CHEMBIOL; MICROBES

Indexed keywords

ALNUS;

EID: 34247202694     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2007.02.008     Document Type: Article

References (56)

1. Stockwell B.R. Exploring biology with small organic molecules. Nature 432 (2004) 846-854
2. Bredul M., and Jacoby E. Chemogenomics: an emerging strategy for rapid target and drug discovery. Nat. Rev. Genet. 5 (2004) 262-275
3. Berg T. Cellular profiling of small-molecule bioactivities: an alternative tool for chemical biology. Angew. Chem. Int. Ed. 44 (2005) 5008-5011
4. Mitchison T.J. Small-molecule screening and profiling by using automated microscopy. ChemBioChem 6 (2005) 33-39
5. Müller O., Gourzoulidou E., Carpintero M., Karaguni I.-M., Langerak A., Herrmann C., Möröy T., Klein-Hitpaß L., and Waldmann H. Identification of potent Ras signalling inhibitors by pathway-selective phenotype-based screening. Angew. Chem. Int. Ed. 43 (2004) 450-454
6. Waldmann H., Karaguni I.-M., Carpintero M., Gourzoulidou E., Herrmann C., Brockmann C., Oschkinat H., and Müller O. Sulindac-derived Ras pathway inhibitors target the Ras-Raf interaction and downstream effectors in the Ras pathway. Angew. Chem. Int. Ed. 43 (2004) 454-458
7. Breinbauer R., Vetter I.R., and Waldmann H. From protein domains to drug candidates - natural products as guiding principles in the design and synthesis of compound libraries. Angew. Chem. Int. Ed. 41 (2002) 2878-2890
8. Koch M.A., and Waldmann H. Protein structure similarity clustering and natural product structure as guiding principles in drug discovery. Drug Discov. Today 10 (2005) 471-482
9. Koch M.A., Wittenberg L.O., Basu S., Jeyaraj D.A., Gourzoulidou E., Reinecke K., Odermatt A., and Waldmann H. Compound library development guided by protein structure similarity clustering and natural product structure. Proc. Natl. Acad. Sci. USA 101 (2004) 16721-16726
10. Charette B.D., MacDonald R.G., Wetzel S., Berkowitz D.B., and Waldmann H. Protein structure similarity clustering. Angew. Chem. Int. Ed. 45 (2006) 7766-7770
11. Koch M.A., Schuffenhauer A., Scheck M., Wetzel S., Casaulta M., Odermatt A., Ertl P., and Waldmann H. Charting biologically relevant chemical space: a structural classification of natural products (SCONP). Proc. Natl. Acad. Sci. USA 102 (2005) 17272-17277
12. Nören-Müller A., Reis-Corrêa Jr. I., Prinz H., Rosenbaum C., Saxena K., Schwalbe H.J., Vestweber D., Cagna G., Schunk S., Schwarz O., et al. Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis. Proc. Natl. Acad. Sci. USA 103 (2006) 10606-10611
13. Nicolaou K.C., Winssinger N., Pastor J., Ninkovic S., Sarabia F., He Y., Vourloumis D., Yang Z., Li T., Gainnakakou P., and Hamel E. Synthesis of epothilones A and B in solid and solution phase. Nature 387 (1997) 268-272
14. Nicolaou K.C., Pfefferkorn J.A., and Cao G.-Q. Selenium-based solid-phase synthesis of benzopyrans I: applications to combinatorial synthesis of natural products. Angew. Chem. Int. Ed. 39 (2000) 734-739
15. 1 analogues. J. Comb. Chem. 1 (1999) 534-539
16. Barun O., Sommer S., and Waldmann H. Asymmetric solid-phase synthesis of 6,6-spiroketals. Angew. Chem. Int. Ed. 44 (2004) 3195-3199
17. Brohm D., Philippe N., Metzger S., Bhargava A., Müller O., Lieb F., and Waldmann H. Solid-phase synthesis of dysidiolide-derived protein phosphatase inhibitors. J. Am. Chem. Soc. 124 (2002) 13172-13178
18. Arya P., Joseph R., Gan Z., and Rakic B. Exploring new chemical space by stereocontrolled diversity-oriented synthesis. Chem. Biol. 12 (2005) 163-180
19. Ortholand J.-Y., and Ganesan A. Natural products and combinatorial chemistry: back to the future. Curr. Opin. Chem. Biol. 8 (2004) 271-280
20. Boldi A.M. Libraries from natural product-like scaffolds. Curr. Opin. Chem. Biol. 8 (2004) 281-286
21. Sanz M.A., Voigt T., and Waldmann H. Enantioselective catalysis on the solid phase: synthesis of natural product-derived tetrahydropyrans employing the enantioselective oxa-Diels-Alder reaction. Adv. Synth. Catal. 348 (2006) 1511-1514
22. Sommer S., and Waldmann H. Solid phase synthesis of a spiro[5.5]ketal library. Chem. Commun. (2005) 5684-5686
23. García A.B., Leßmann T., Umayre J.D., Mamane V., Sommer S., and Waldmann H. Stereocomplementary synthesis of a natural product-derived compound collection on a solid phase. Chem. Commun. (2006) 3868-3870
24. Meseguer B., Alonso-Diaz D., Griebenow N., Herget T., and Waldmann H. Natural product synthesis on polymeric supports - synthesis and biological evaluation of an indolactam library. Angew. Chem. Int. Ed. 38 (1999) 2902-2906
25. Lewy D.S., Gauss C.-M., Soenen D.R., and Boger D.L. Fostriecin: chemistry and biology. Curr. Med. Chem. 9 (2002) 2005-2032
26. Kalesse M., and Christmann M. The chemistry and biology of the Leptomycin family. Synthesis (2002) 981-1003
27. Watanabe H., Watanabe H., Bando M., Kido M., and Kitahara T. An efficient synthesis of pironetins employing a useful charal building block, (1S, 5S, 6R)-5-hydroxybicyclo[4.1.0]reptan-2-one. Tetrahedron 55 (1999) 9755-9776
28. Ramachandran P.V., Reddy M.V.R., and Brown H.C. Asymmetric synthesis of goniothalamin, hexadecanolide, massoia lactone, and parasorbic acid via sequential allylboration ring-closing metathesis reactions. Tetrehedron Lett. 41 (2000) 583-586
29. Collett L.A., Davies M.T., and Rivett D.E.A. Naturally occurring 6-substituted 5,6-dihydro-α-pyrones. Fortschr. Chem. Org. Naturst. 75 (1998) 182-209
30. Davies M.T., and Rivett D.E.A. Naturally occurring 6-substituted 5,6-dihydro-α-pyrones. Fortschr. Chem. Org. Naturst. 55 (1989) 1-35
31. Mikami K., Motoyama Y., and Terada M. Asymmetric catalysis of Diels-Alder cycloadditions by an MS-free binaphthol-titanium complex: dramatic effect of MS, linear vs. nonlinear relationship, and synthetic applications. J. Am. Chem. Soc. 116 (1994) 2812-2820
32. Christmann M., Bhatt U., Quitschalle M., Claus E., and Kalesse M. Total synthesis of (+)-ratjadone. Angew. Chem. Int. Ed. 39 (2000) 4364-4366
33. Quitschalle M., Christmann M., Bhatt U., and Kalesse M. Synthesis of unsaturated lactone moieties by asymmetric hetero Diels-Alder reactions with binaphthol-titanium complexes. Tetrahedron Lett. 42 (2001) 1263-1265
34. Dossetter A.G., Jamison T.F., and Jacobsen E.N. Highly enantio- and diastereoselective hetero-Diels-Alder reactions catalyzed by new chiral tridentate chromium (III) catalysts. Angew. Chem. Int. Ed. 38 (1999) 2398-2400
35. Chavez D.E., and Jacobsen E.N. Total synthesis of fostriecin (CI-920). Angew. Chem. Int. Ed. 40 (2001) 3667-3670
36. Yli-Kauhaluoma J. Diels-Alder reactions on solid supports. Tetrahedron 57 (2001) 7053-7071
37. 3-catalyzed solid-phase [4+2] heterocycloadditions: an efficient asymmetric process in catalyst-recycling conditions. Tetrahedron Lett. 42 (2001) 8849-8852
38. Stavenger R.A., and Schreiber S.L. Asymmetric catalysis in diversity-oriented organic synthesis: enantioselective synthesis of 4320 encoded and spatially segregated dihydropyranocarboxamides. Angew. Chem. Int. Ed. 40 (2001) 3417-3421
39. Kurosu M., Porter J.R., and Foley M.A. An efficient synthesis of indane-derived bis(oxazoline) and its application to hetero Diels-Alder reactions on polymer support. Tetrahedron Lett. 45 (2004) 145-148
40. Leßmann T., and Waldmann H. Enantioselective synthesis on the solid phase. Chem. Commun. (2006) 3380-3389
41. Bialy L., Lopez-Canet M., and Waldmann H. Determination of the relative configuration of the C-2-C-1′-fragment of cytostatin. Synthesis (2002) 2096-2104
42. Bialy L., and Waldmann H. Total synthesis and biological evaluation of the protein phosphatase 2A inhibitor cytostatin and analogues. Chem. Eur. J. 10 (2004) 2759-2780
43. Bialy L., and Waldmann H. Synthesis of the protein phosphatase 2A inhibitor (4S, 5S, 6S, 10S, 11S, 12S)-cytostatin. Angew. Chem. Int. Ed. 41 (2002) 1748-1751
44. Bialy L., and Waldmann H. Synthesis and biological evaluation of cytostatin analogues. Chem. Commun. 15 (2003) 1872-1873
45. Bhatt U., Christmann M., Quitschalle M., Claus E., and Kalesse M. The first total synthesis of (+)-ratjadone. J. Org. Chem. 66 (2001) 1885-1893
46. Watanabe Y., Ishikawa S., Takao G., and Toru T. Radical cyclization on solid support: synthesis of γ-butyrolactones. Tetrahedron Lett. 40 (1999) 3411-3414
47. Kim S.W., Hong C.Y., Lee K., Lee E.J., and Koh J.S. Solid phase synthesis of benzylamine-derived sulfonamide library. Bioorg. Med. Chem. Lett. 8 (1998) 735-738
48. Thutewohl M., and Waldmann H. Solid-phase synthesis of a pepticinnamin E library. Bioorg. Med. Chem. 11 (2003) 2591-2615
49. Thutewohl M., Kissau L., Popkirova B., Karaguni I.-M., Nowak T., Bate M., Kuhlmann J., Müller O., and Waldmann H. Solid-phase synthesis and biological evaluation of a pepticinnamin E library. Angew. Chem. Int. Ed. 41 (2002) 3616-3620
50. Kondoh M., Usui T., Kobayashi S., Tsuchiya K., Nishikawa K., Nishikiori T., Mayumi T., and Osada H. Cell cycle arrest and antitumor activity of pironetin and its derivatives. Cancer Lett. 126 (1998) 29-32
51. Kondoh M., Usui T., Nishikiori T., Mayumi T., and Osada H. Apoptosis induction via microtubule disassembly by an antitumor compound, pironetin. Biochem. J. 340 (1999) 411-416
52. Usui T., Watanabe H., Nakayama H., Tada Y., Kanoh N., Kondoh M., Asao T., Takio K., Watanabe H., Nishikawa K., et al. The anticancer natural product pironetin selectively targets Lys352 of α-tubulin. Chem. Biol. 11 (2004) 799-806
53. Mayer T.U., Kapoor T.M., Haggarty S.J., King R.W., Schreiber S.L., and Mitchtison T.J. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 286 (1999) 971-974
54. Haggarty S.J., Mayer T.U., Miyamoto D.T., Fathi R., King R.W., Mitchison T.J., and Schreiber S.L. Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis. Chem. Biol. 4 (2000) 275-286
55. Miyamoto D.T., Perlman Z.E., Mitchison T.J., and Shirasu-Hiza M. Dynamics of the mitotic spindle - potential therapeutic targets. Prog. Cell Cycle Res. 5 (2003) 349-360
56. Pelkmans L., Fava E., Grabner H., Hannus M., Habermann B., Krausz E., and Zerial M. Genome-wide analysis of human kinases in clathrin- and cavaeolae/raft-mediated endocytosis. Nature 436 (2005) 78-86